Analyse de l'application Corsano pour le 22 mars

The CardioWatch 287 is a medically certified wireless remote monitoring system intended for continuous collection of physiological data in home and healthcare settings. CardioWatch 287 is a CE medical device certified under EU-MDR standards. This includes Pulse Rate, SpO2, Core Body Temperature, Blood Pressure, Respiration Rate, Activity and Sleep. Data is transmitted wirelessly from the device via the application to the health cloud where it is stored and made available for further analysis. Due to their non-intrusive and convenient nature, Corsano’s CardioWatch 287 devices have great potential for high volume accessible long-term monitoring at-risk patients. The comfortable and robust ergonomic design of CardioWatch 287 is small, light and user-friendly, making it suitable for deployment in patient populations or the elderly. About Corsano Health: Corsano Health, based in The Netherlands with offices in Switzerland, is a leading wearable MedTech company developing, producing and marketing medical smart monitoring devices designed to measure vital parameters 24/7 using wireless, non-invasive, and medical-grade technology. Corsano Health is medically certified complying with Annex IX (MDR) and EN-ISO 13485 standards. The Corsano brand name is derived from in corpore sano (in a healthy body). Corsano’s CardioWatch 287 is a cardiac arrhythmia screening system that provides a simple and effective method for continuous monitoring of up to 19 vital parameter measurements (i.e., Pulse Rate, SpO2, Core Body Temperature, Blood Pressure, Respiration Rate, Activity, Sleep, ECG, BIOZ, ACC, PPG). More information at http://www.corsano.com This application is only supported by phones with Bluetooth® 5.0 Low Energy For Non European customers, CardioWatch 287 is available as Investigative device to collect body metrics data. The device is not used for medical diagnostic or treatment. No physical harm risk.